TONYA HYLANDER: Open Payments
NPI 1841272580 · OLIVE BRANCH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $710 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $107 |
| Amgen Inc. | 1 | $88 |
| Abbott Laboratories | 1 | $86 |
| Smith+Nephew, Inc. | 3 | $75 |
| Averitas Pharma Inc. | 2 | $67 |
| Boston Scientific Corporation | 3 | $53 |
| Reprise Biomedical, Inc. | 2 | $41 |
| Medtronic, Inc. | 2 | $38 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
| ABBVIE INC. | 1 | $26 |
Products named: JARDIANCE, REPATHA, ENSITE, COLLAGENASE SANTYL, QUTENZA, VENASEAL, NUZYRA, UBRELVY.
Industry payments across MS — which companies pay providers there.
